| 2026-08-14 | 10-Q | 10.9 | Form of Unsecured Convertible Promissory Note, dated May 5, 2026. |
|---|
| 2026-08-14 | 10-Q | 10.6 | Form of Promissory Note, dated July 6, 2026 |
|---|
| 2026-08-14 | 10-Q | 10.5 | Form of Promissory Note, dated July 2, 2026 |
|---|
| 2026-07-30 | 8-K | 10.5 | Consulting Agreement dated July 26, 2026, between Brainstorm Cell Therapeutics, Inc. and Ibrahim Dagher, MD. |
|---|
| 2026-07-30 | 8-K | 10.4 | Restricted Stock Unit Grant Notice dated July 24, 2026, between Brainstorm Cell Therapeutics Inc. and Jacob Frenkel, Ph.D. |
|---|
| 2026-07-30 | 8-K | 10.3 | Consulting Agreement dated July 24, 2026, between Brainstorm Cell Therapeutics Inc. and Jacob Frenkel, Ph.D. |
|---|
| 2026-07-30 | 8-K | 10.2 | Stock Option Grant Notice dated July 24, 2026, between Brainstorm Cell Therapeutics Inc. and Peter Pitts. |
|---|
| 2026-07-30 | 8-K | 10.1 | Offer Letter dated July 24, 2026, between Brainstorm Cell Therapeutics Inc. and Peter Pitts. |
|---|
| 2026-05-28 | 8-K | 10.1 | Form of Director Indemnification Agreement |
|---|
| 2026-05-15 | 10-Q | 10.4 | Form of Common Warrant, dated May 11, 2026. |
|---|
| 2026-05-15 | 10-Q | 10.3 | Form of Securities Purchase Agreement, dated May 11, 2026. |
|---|
| 2026-05-15 | 10-Q | 10.2 | Form of Promissory Note, issued May 11, 2026, to Vanquish Funding Group Inc. |
|---|
| 2026-05-15 | 10-Q | 10.1 | Form of Securities Purchase Agreement, dated May 11, 2026, between the Company and Vanquish Funding Group Inc. |
|---|
| 2026-02-27 | 8-K | 10.15 | Amendment No. 6 to Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan. |
|---|
| 2026-02-27 | 8-K | 10.8 | Amendment No. 6 to Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. |
|---|
| 2026-02-27 | 8-K | 10.1 | Securities Purchase Agreement, dated February 24, 2026 |
|---|
| 2026-02-13 | 8-K | 10.1 | Securities Purchase Agreement, dated February 9, 2026 |
|---|
| 2026-01-09 | 8-K | 10.6 | Convertible Promissory Note, issued January 6, 2026, to Auctus Fund, LLC. |
|---|
| 2026-01-09 | 8-K | 10.5 | Securities Purchase Agreement, dated January 6, 2026, by and between the Company and Auctus Fund, LLC. |
|---|
| 2026-01-09 | 8-K | 10.4 | Convertible Promissory Note, issued January 5, 2026, to Quick Capital, LLC. |
|---|
| 2026-01-09 | 8-K | 10.3 | Note Purchase Agreement, dated January 5, 2026, by and between the Company and Quick Capital, LLC. |
|---|
| 2026-01-09 | 8-K | 10.2 | Promissory Note, issued December 31, 2025, to Vanquish Funding Group Inc. |
|---|
| 2026-01-09 | 8-K | 10.1 | Securities Purchase Agreement, dated December 31, 2025, by and between the Company and Vanquish Funding Group Inc. |
|---|